Mr. Ronald Funk reports
AURORA CANNABIS ANNOUNCES APPOINTMENT OF NEW INDEPENDENT DIRECTOR
Aurora Cannabis Inc. has appointed Theresa Firestone to the company's board of directors, effective today. This is a newly created directorship that expands the board to nine members, seven of whom are independent.
Ms. Firestone joins the board following a distinguished career as a senior health care executive with leadership positions in Canada, Europe and Asia. An expert in strategic planning, operations and new business development, Ms. Firestone has served in various sectors such as retail, health care, pharmaceuticals and government. Her experience includes over 20 years of international P&L (profit and loss) management, 15 years in senior roles at Pfizer Inc., over 10 years at the Ontario Ministry of Health, and seven years in retail and health and wellness, including Shoppers Drug Mart, where she oversaw the design and launch of the company's medical cannabis business. In addition, Ms. Firestone has more than 20 years of public and private board experience, including with Orion Biotechnology, Merus Labs International and several not-for-profit organizations.
Ronald Funk, chairman of Aurora Cannabis, stated: "We are delighted to welcome Theresa to our board of directors. She brings to us extensive expertise in health care management and pharmaceuticals, global business restructuring, new business development, and a proven ability to lead and manage change. Her background and well-defined skill set will be invaluable to us as we execute our strategic growth plans while managing costs more effectively. We look forward to benefiting from her many contributions to Aurora."
Ms. Firestone holds a bachelor of applied science from the University of Guelph and completed the executive leadership program at Harvard Business School. Accolades include induction into the Canadian Healthcare Marketing Hall of Fame, being honoured as one of 12 Outstanding Canadian Women by the Weizman Institute and being awarded the prestigious Queen's Golden Jubilee medal.
About Aurora Cannabis Inc.
Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and Reliva CBD. Driven by science and innovation and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched.
Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB" and is a constituent of the S&P/TSX Composite Index.
We seek Safe Harbor.
© 2021 Canjex Publishing Ltd. All rights reserved.